PATENT CLAIM ANALYSIS

Application Number: 15887214
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["546", "160000"]

Abstract:
Disclosed are compounds of Formula (I) or a salt thereof, wherein: A is CR 1  or N; B is CR 3  or N; D is CR 4  or N; L 1  is —(CR 7 R 7 ) m —; L 2  is —(CR 7 R 7 ) n —; and X, Z, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6  are define herein. Also disclosed are methods of using such compounds as modulators of TNFα, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.

Claim (Index 9):
A method for treating a disease comprising the administration to a subject in need thereof a therapeutically-effective amount of at least one compound according to  claim 1 , wherein said disease is an inflammatory or autoimmune disease.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 2.06897
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15749611', '15558692', '15558708', '15558724', '14588470']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8270936609181994
- 35 USC 102 Novelty (BERT): 0.5565392675960475
- Combined Prediction Score: 0.8000382215859843
- Mean Citation Score: 430.14112400000016
- Max Citation Score: 456.6969
- Similarity Product: 356.97231681493525

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test